Can You Trust eDetailing Surveys?
When using surveys to measure ROI of marketing campaigns -- such as surveys about physician use of eDetailing -- marketers should be wary of comparing one survey's results with another.
cDetailing: Addressing the Consumer Education Gap
Consumer Detailing by Medsite is a novel rich-media online consumer disease education and drug information program.
The Evolving Impact of Anti-Spam Legislation on Online Marketers
In the last year the FTC has issued regulations that set forth additional requirements under the federal CAN-SPAM act that you should be aware of.
Patient Detailing at the Point of Care
There are several new strategies and solutions available to pharmaceutical marketers that are designed to increase the education quotient of pharma marketing communications. One such solution is wireless Webpad developed by Phreesia for deployment in doctors' offices.
Midwestern eMarketing Values
Siren Interactive, a midwestern interactive eMarketing firm, believes that valuable Internet content is a prime component to an effective eMarketing strategy for pharmaceutical companies
It’s the Science, Stupid!
There is no doubt that the industry needs to do a much better job communicating drug benefits and risks to consumers. How will they do this if the population at large is scientifically illiterate? Also, how can the drug industry focus on this problem if its leaders are not grounded in science?
Restrict DTC, but Extend the Patent for New Drugs
When the leading Republican member of Congress and a contender for the next president of the United States says it's time for the pharmaceutical industry to 'clean up it's act' and suggests banning DTC advertising of new drugs for 2 years after launch, you know that you are in trouble. Should the industry fight back or 'suffer the slings and arrows of politicians' until it all blows over? If it fights back, how should it fight back?
To Ban or Not to Ban DTC? That Was the Question!
This article takes a critical look at Sen. Frist's proposal to reform DTC. The article includes reactions to the Frist proposal from PhRMA, AMA, advertising trade associations, and from members of the PHARMA-MKTING online discussion group.
Marketing the Pharma Industry: The Empire Strikes Back
This article gives a spirited review of a recent Pharmaceutical Marketers Knowledgeshare Forum and includes a composite overview of the action plan developed by attendees for the pharma industry to regain trust.
Translate Industry Trends into the Optimal Promotional Strategy
This is a summary of a recent presentation by David L. Stern, Vice President of Marketing for Metabolic and Endocrinology at Serono, Inc. Stern spoke from a marketer's perspective about recent trends in the pharmaceutical industry and how to address them by developing better marketing programs.
